Interferon Production by Human Lymphoblastoid Cell Lines of Different
Origins (Accepted 24 July 1980) SUMMARY 150 lymphoblastoid cell lines derived from normal individuals or from subjects with various clinical conditions were induced to form interferon by treatment with Sendal virus. Irrespective of the status of the donor, most of the lines produced some interferon and 22 produced considerable amounts (more than 3000 international units/ml). Lines derived from infectious mononucleosis patients were good interferon producers while those from leukaemic donors were poor producers. The data suggest that the clinical conditions of the donor and the source of transforming virus may influence the quantity of interferon produced by a given cell line.
We have screened a large number of human lymphoblastoid cell lines for their potential to form interferon. Most of the lines came from the collection of the Medical Research Council Clinical and Population Cytogenetics Unit, Edinburgh. Others were kindly supplied by Dr I. Gresser, Villejuif, Dr J. Minowada, Buffalo, and Professor M. A. Epstein, Bristol. Some had grown spontaneously but many had been established by co-cultivation of blood lymphocytes with Epstein-Barr virus (EBV) from pre-existing lines (Steel, 1972) . Cells were grown in medium RPMI 1640 supplemented with 10% foetal calf serum, 1.1% NaHCO 3, 200 units/ml penicillin and 100 units/ml streptomycin. The method used to screen the cells for interferon production has been described (Christofinis & Finter, 1977) . Interferons were assayed by the dye-uptake method (Finter, 1969; Johnston et al., 1980) in cells of the V3 vervet monkey kidney cell line (Christofinis, 1970) which were challenged with Semliki Forest virus. Titres are expressed in this paper in international units in terms of the standard, B69/19. 150 cell lines were tested for their ability to produce interferon in response to Sendal virus, each line being tested two to four times. On each occasion one or two cultures of Namalwa cells (Klein et al., 1972; Strander et al., 1975) were included and these served as a positive control for the adequacy of the interferon induction conditions.
Of the cell lines tested, 42% produced little or no interferon, whereas 14% produced relatively large amounts [more than 3000 (3.5 log) units/ml]. Based on the mean interferon titres obtained, we assigned each cell line tested to one of five groups. The findings are analysed in terms of cell line origin for the total collection (Table 1 ) and for the source of the EBV used in the co-cultivation procedure (Table 2) .
Our data confirm that the ability to produce interferon is a fairly general property of human lymphoblastoid cell lines, whether spontaneously established or transformed by the addition of EBV in vitro, as previously reported (Zajac et al., 1969; Haase et al., 1970) . Certain trends not previously recorded are, however, apparent from our results.
We noted that a high percentage (61%) of the spontaneously developed cell lines were poor interferon producers, whereas of the cell lines transformed by the addition of EBV in vitro, 65 % produced relatively high levels of interferon (at least 2.5 log units/ml). The two categories are, of course, not strictly comparable since, for example, many cell lines transformed by virus in vitro were of foetal or neonatal origin, whereas the spontaneously developed lines were mainly from adults.
0022-1317/81/0000-4132 $02.00 © 1981 S GM Analysing the results in relation to the clinical conditions of the donor, we observed that 29 out of 34 spontaneously established cell lines derived from leukaemic donors were low interferon producers, whereas 10 out of 13 cell lines derived from mononucleosis donors, were high-titre interferon producers, so that these clinical conditions seem to have some bearing on the quantity of interferon produced by the corresponding cell lines. Thus the relatively high proportion of cell lines derived from leukaemic patients included in the spontaneously developed group may have influenced the quantitative distinction betwen these and the in vitro transformed lines, mentioned above. Lee et al. (1966) studied the production of interferon by leukocytes obtained directly from patients with various forms of leukaemia and their results suggest that leukocytes from patients with lymphocytic leukaemia produce relatively little interferon in response to virus inducers. Interestingly, we obtained similar results with cell lines derived from leukaemic patients.
Examining the results in relation to the source of transforming virus, we observe that strain KIB 2 gave a ratio of 5 : 1 and B-95-8 and F 137 a ratio of 2 : 1 in favour of cell lines producing large amounts of interferon. In contrast, virus strain MAR~ gave a ratio of 1 : 1 and strain BEC-11 gave a ratio of 1 : 2. The numbers involved are small, but it seems that the inducing virus strain may be of some significance in relation to the interferon-producing capacity of a cell line. Our hypothesis is that this may reflect the relative EBV load/cell at the time when the cell line is established. The number of infectious EBV particles in the crude preparations used for transformation in vitro almost certainly differ widely, and lines established by the addition of exogenous virus were probably exposed to more virus particles than those lines transforming 'spontaneously'; of the latter, those derived at the time of acute primary infection with EBV (i.e. infectious mononucleosis) are likely to have had the heaviest exposure to virus.
Among the lines screened were several sets of two or more derived from the same individual, which nevertheless differed quite markedly in their levels of interferon production. Thus the genetic constitution of the donor is not a major factor in this context. 
